Safety and Efficacy of the Maximum Tolerated Dose of Givinostat in Polycythemia Vera: A Two-Part Phase Ib/Ii Study
Leukemia - United Kingdom
doi 10.1038/s41375-020-0735-y
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2020
Authors
Publisher
Springer Science and Business Media LLC